These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [The practice of chemotherapy with the DeVita protocol]. Gassmann W, Schmitz N, Löffler H. Dtsch Med Wochenschr; 1982 Jul 09; 107(27):1063-9. PubMed ID: 6177488 [No Abstract] [Full Text] [Related]
3. Combination chemotherapy in advanced and recurrent Hodgkin's disease. McElwain TJ, Wrigley PF, Hunter A, Crowther D, Malpas JS, Peckham MJ, Smithers DW, Fairley GH. Natl Cancer Inst Monogr; 1973 May 09; 36():395-402. PubMed ID: 4744597 [No Abstract] [Full Text] [Related]
4. Long term experience with combination chemotherapy in advanced Hodgkin's disease. Garrett MJ, Das S, Smith JD, Freedman LS. Clin Oncol; 1977 Jun 09; 3(2):145-54. PubMed ID: 68843 [No Abstract] [Full Text] [Related]
6. [Chemotherapy of Hodgkin's disease]. Amiel JL, Mathé G. Rev Prat; 1974 Oct 11; 24(45):3957-60, 3963-4, 3967-8. PubMed ID: 4141118 [No Abstract] [Full Text] [Related]
7. [Successful chemotherapy of cancer. Remission of Hodgkin's disease. IV]. Lopez M. Clin Ter; 2001 Oct 11; 152(3):203-6. PubMed ID: 11692542 [No Abstract] [Full Text] [Related]
8. The treatment of Hodgkin's disease. Fairley GH. Trans Med Soc Lond; 1972 Oct 11; 88():61-71. PubMed ID: 4665820 [No Abstract] [Full Text] [Related]
9. Combined drug treatment of Hodgkin's disease: remission induction, remission duration, and survival; an appraisal. DeVita VT. Natl Cancer Inst Monogr; 1973 May 11; 36():373-9. PubMed ID: 4744596 [No Abstract] [Full Text] [Related]
10. [Treatment of Hodgkin's disease. Experience of the Hôpital Saint-Louis]. Boiron M, Teillet F, Weisgerber C, Dana M, Jacquillat C, Bernard J. Rev Prat; 1974 Oct 11; 24(45):3971-8. PubMed ID: 4445767 [No Abstract] [Full Text] [Related]
11. [Hodgkin's disease: treatment of clinical stages II3+A, IB, IIB, IIIA and IIIB with short chemotherapy (3 MOPP, or 3 CVPP), splenectomy and limited irradiation. Results after 4 years of a prospective protocol including 94 patients]. Andrieu JM, Casassus P, Coscas Y, Darmont J, Goubeau C, Katz M, Jacquillat C, Tricot G, Weil M. Bull Cancer; 1982 Oct 11; 69(4):321-9. PubMed ID: 6897520 [No Abstract] [Full Text] [Related]
13. [10 years of DeVita protocol]. Gassmann W, Schmitz N, Löffler H. Dtsch Med Wochenschr; 1982 Jul 09; 107(27):1043-4. PubMed ID: 6896303 [No Abstract] [Full Text] [Related]
14. Hodgkin's disease in a patient after treatment for angioimmunoblastic lymphadenopathy. Melato M, Falconieri G, Giammarini Barsanti A, Mottola A. Haematologica; 1983 Jul 09; 68(5):675-9. PubMed ID: 6416946 [No Abstract] [Full Text] [Related]
15. Chemotherapy of Hodgkin's disease in studies by acute leukemia group B. Nissen NI, Stutzman L, Holland JF, Glidewell OJ. Arch Intern Med; 1973 Mar 09; 131(3):396-401. PubMed ID: 4688038 [No Abstract] [Full Text] [Related]
17. Chemotherapy as a primary treatment of Hodgkin's disease (204 new cases, 1 to 8 years of follow-up). Jacquillat C, Weil M, Auclerc G, Desprez-Curely JP, Chastang C, Garçon C, Chantalou JP, Gemon-Auclerc MF, Delobel J, Dana M, Tanzer J, Teillet F, Izrael V, Chelloul N, Weisgerber C, De Heaulme M, Boiron M, Bernard J. Eur J Cancer (1965); 1975 Oct 09; 11(10):679-88. PubMed ID: 1204663 [No Abstract] [Full Text] [Related]
18. Greater curability in advanced Hodgkin's disease? Portlock CS. Cancer J Sci Am; 1999 Oct 09; 5(5):264-5. PubMed ID: 10526665 [No Abstract] [Full Text] [Related]
19. Letter: Chemotherapy of Hodgkin's disease. Winokur SH. N Engl J Med; 1974 Dec 12; 291(24):1309. PubMed ID: 4431438 [No Abstract] [Full Text] [Related]
20. Pediatric Hodgkin's disease. Oliapuram Jose B, Koerner P, Bertolone S, Patel CC, Spanos WJ, Paris KJ, Silverman CL, Yashar CM. J Ky Med Assoc; 2004 Mar 12; 102(3):104-6. PubMed ID: 15067795 [Abstract] [Full Text] [Related] Page: [Next] [New Search]